Psoriasis of special localizations. Experience with the use of the interleukin-17A inhibitor netakimab for the treatment of psoriasis of special localizations
Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study